Bausch Health Hit With $75M Suit Alleging Botched Drug Deal
A Chicago generic-drug maker claimed Wednesday that several Bausch Health units breached their contractual responsibility to help develop and market treatments for eye inflammation and infections, saying the alleged failures caused...To view the full article, register now.
Already a subscriber? Click here to view full article